Preservision   3

Background
The Department of Veterans Affairs (VA) and the Department of Defense (DOD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor Programs (PPV). The PPV Programs are separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government contracts. This solicitation aims to establish a supply source that will provide drugs listed in the schedule for purchase through the PPV Programs. The objective is to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The solicitation is for Preservision AREDS with Lutein and Preservision AREDS 2. One award will be made in the aggregate for line items 1 and 2. Offerors must submit a price for the base year and all four one-year options for both line items. Prices offered shall not exceed two decimal places. Offered prices must include a Cost Recovery Fee of 0.5%. Offerors must list a UPC number for each offered drug that is unique to the offeror's company. The contract will have a base year with four one-year option periods.

Period of Performance
The contract will have a base year with four one-year option periods.

Place of Performance
The drugs must be made available for patients with macular degeneration at various facilities including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DOD) Pharmaceutical Prime Vendor Program, Indian Health Service (IHS) facilities, Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.